InvestorsHub Logo
Followers 32
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

Re: None

Thursday, 04/20/2017 5:04:15 PM

Thursday, April 20, 2017 5:04:15 PM

Post# of 346545
good recon..

http://www.fiercebiotech.com/biotech/novartis-drug-development-chief-outlines-car-t-research-commitment

“To give this technology the best chance of succeeding, and in the most cost-effective way, we decided we should integrate [the unit] into our normal operations, and so CAR-T agents were then no different to an I-O agent, or anything else that we developed at Novartis, other than the fact that the process here is very important for the product," he said. “We have the scale to work on these sorts of things quickly. So, the integration has allowed us to work on multiple programs in parallel, where I think the unit was focusing on just one or two programs at a time.”

does working with IST's give the tech the best chance of succeeding?

and one question regarding BOD. in your opinion, did ES have influence over CJ as directors during their tenure?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News